Evotec SE (OTCMKTS:EVTCY – Get Free Report)’s share price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $4.17 and traded as low as $3.84. Evotec shares last traded at $4.03, with a volume of 153,406 shares traded.
Evotec Price Performance
The company has a market cap of $1.33 billion, a price-to-earnings ratio of 9.83 and a beta of 0.98. The company’s 50 day moving average price is $3.70 and its 200 day moving average price is $4.17. The company has a current ratio of 2.57, a quick ratio of 2.50 and a debt-to-equity ratio of 0.53.
Evotec Company Profile
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Featured Articles
- Five stocks we like better than Evotec
- Why Are Stock Sectors Important to Successful Investing?
- Pfizer’s 7.5% Dividend: Income Haven or House of Cards?
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- 3 Trades Members of Congress Are Making Right Now
- What is the Euro STOXX 50 Index?
- TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
